Marietta Investment Partners’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.14M Hold
20,019
0.54% 51
2026
Q1
$3.06M Buy
20,019
+1,782
+10% +$273K 0.61% 51
2025
Q4
$2.51M Buy
18,237
+488
+3% +$63.9K 0.5% 56
2025
Q3
$2.28M Buy
17,749
+645
+4% +$78.7K 0.44% 58
2025
Q2
$2.07M Sell
17,104
-600
-3% -$67.6K 0.45% 54
2025
Q1
$1.97M Sell
17,704
-110
-0.6% -$11.7K 0.48% 56
2024
Q4
$1.73M Sell
17,814
-3,340
-16% -$356K 0.38% 59
2024
Q3
$2.43M Sell
21,154
-250
-1% -$28.4K 0.52% 52
2024
Q2
$2.28M Sell
21,404
-140
-0.6% -$14.1K 0.5% 52
2024
Q1
$2.08M Buy
21,544
+392
+2% +$40.2K 0.46% 56
2023
Q4
$2.14M Buy
21,152
+7,680
+57% +$741K 0.53% 54
2023
Q3
$1.37M Buy
13,472
+90
+0.7% +$9.13K 0.38% 60
2023
Q2
$1.35M Buy
+13,382
New +$1.34M 0.35% 63
2021
Q3
Sell
-2,362
Closed -$216K 184
2021
Q2
$216K Buy
+2,362
New +$210K 0.05% 175
2021
Q1
Sell
-2,128
Closed -$201K 174
2020
Q4
$201K Buy
+2,128
New +$186K 0.05% 154
2016
Q1
Sell
-11,028
Closed -$850K 136
2015
Q4
$850K Sell
11,028
-2,366
-18% -$188K 0.34% 70
2015
Q3
$1.08M Sell
13,394
-3,933
-23% -$350K 0.42% 51
2015
Q2
$1.53M Buy
17,327
+7,243
+72% +$664K 0.59% 43
2015
Q1
$891K Buy
10,084
+2,857
+40% +$253K 0.35% 64
2014
Q4
$600K Buy
+7,227
New +$599K 0.24% 67

Other funds holding NVS

Marietta Investment Partners's NVS Position: Q2 2026 in Review

Marietta Investment Partners held its Novartis (NVS) position steady in Q2 2026 at 20,019 shares worth $3.14M. The position accounts for 0.54% of the portfolio, ranked #51.

Marietta Investment Partners first reported a position in NVS in Q4 2014 and has held it in 20 quarters since. 1,449 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Marietta Investment Partners held 20,019 shares of Novartis worth $3.14M as of Q2 2026.
  • Marietta Investment Partners left its Novartis share count unchanged in Q2 2026.
  • Novartis made up 0.54% of Marietta Investment Partners's portfolio in Q2 2026, its #51 holding.
  • Marietta Investment Partners first reported a position in Novartis in Q4 2014 and has held it in 20 quarters since.
  • 1,449 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Marietta Investment Partners's 13F filing for Q2 2026, filed 12 Aug 2026.